Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cytoflavin for Prevention of Cognitive Decline in Elderly Surgical Patients
NCT03849664Phase 3Completed
- Sponsor
- POLYSAN
- Start
- Jun 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Post-operative cognitive dysfunction (POCD) comparing Cytoflavin with Placebo (2 arms). Primary endpoint: Montreal Cognitive Assessment at 32 days. Started Jun 2017; status: completed.
02
Drugs
Cytoflavin
03
Conditions
Post-operative cognitive dysfunction (POCD)
Beyond the preview
Go deeper on NCT03849664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03849664.